---
id: 14
title: Schedule
date: 2015-08-21T01:23:22+00:00
author: admin
layout: page
guid: http://www.sacbmeeting.org/?page_id=14
---
Invited talks are limited to 30 minutes with 10 minutes for questions. Selected talks will be limited to 12 minutes with 3 minutes for questions.

## Sunday, April 3rd, 2016

* * *

###### Check-In (2:00 &#8211; 9:00pm)

###### Dinner (5:30 &#8211; 7:00pm)

###### Keynote (7:00 &#8211; 8:00pm)

[Galit Lahav](http://lahav.med.harvard.edu/): &#8220;Therapy guided by protein dynamics in single cells&#8221;

###### Sponsored Mixer (8:30 &#8211; 10:30pm)

## Monday, April 4th, 2016

* * *

######  Breakfast (7:00 &#8211; 8:30pm)

Registration for lunch with the PIs

###### Cancer genomics and gene regulation (9:00 &#8211; 10:40am)

  * [Ben Raphael](http://compbio.cs.brown.edu/): Computational Characterization of Mutational Heterogeneity in Cancer
  * Julia Lima Fleck: &#8220;Integrating mutation and gene expression cross-sectional data to infer cancer progression&#8221;
  * Jiguang Wang: &#8220;Clonal Evolution of Glioblastoma under Therapy&#8221;
  * Pau Creixell: &#8220;Kinome-wide Decoding of Determinants of Specificity and Network Attacking Mutations Rewiring Cancer Signaling&#8221;
  * Kevin Brennan: &#8220;DNA methylation subtyping of head and neck squamous cell carcinoma reveals smoking as a determinant of prognosis and embryonic stem cell-like transcriptional identity&#8221;

###### Poster Session 1 (10:45 &#8211; 12:00pm)

With coffee

###### Lunch (12:15 &#8211; 1:30pm)

###### Tumor Systems Biology I: Migration and Metastasis (1:45 &#8211; 3:25pm)

  * Invited Speaker: [Shelly Peyton](http://www.peytonlab.org/): &#8220;Synthetic Environments to Predict Metastatic Risk and Drug Response&#8221;
  * Pilhwa Lee: &#8220;Physical mechanisms of cancer in the transition to metastasis&#8221;
  * Annelien Zweemer: &#8220;Apoptosis-mediated AXL activation: contribution to metastatic cancers?&#8221;
  * Julia Sero: &#8220;Multiparametric analysis of YAP/TAZ regulation by focal adhesion signaling&#8221;
  * Jorge G.T. Zanudo: &#8220;Combinatorial interventions lend insight into the inhibition of TGFß-driven epithelial-mesenchymal transition and the existence of hybrid epithelial-mesenchymal phenotypes&#8221;

###### Translational Systems Biology (3:45 &#8211; 5:25pm)

  * Invited Speaker: [Andrea Bild](http://pharmacy.utah.edu/pharmtox/faculty/bild.htm): &#8220;Combating Subclonal Evolution of Resistant Cancer Phenotypes&#8221;
  * John Shen: &#8220;A network of deeply conserved synthetic-lethal interactions for exploration of precision cancer therapy&#8221;
  * Wendy Fantl: &#8220;Molecular heterogeneity of ovarian cancer revealed by high-dimensional mass cytometric profiling&#8221;
  * Jiyang Yu: &#8220;Systems biology and functional genomics identifies HDAC6 as a non-oncogene addiction hub for inflammatory breast cancers&#8221;
  * Mohammad Esfahani: &#8220;Noninvasive Cancer
  
    Classification Using Diverse Genomic Features in Circulating Tumor DNA&#8221;

###### Dinner (5:45 &#8211; 7:15pm)

###### AECCSB Business Session  (7:15 &#8211; 8:15pm)

###### Mixer (8:30 &#8211; 10:30pm)

## Tuesday, April 5th, 2016

* * *

###### Breakfast (7:00 &#8211; 8:30am)

###### Tumor Systems Biology II: Microenvironment & Immunotherapy (9:00 &#8211; 10:40 am)

  * Invited Speaker: [Yvonne Chen](http://yvchen.bol.ucla.edu/): &#8220;Engineering Smarter and Stronger T Cells for Cancer Immunotherapy&#8221;
  * Molly Carroll: &#8220;Decoding the role of macrophages in ovarian cancer metastasis through a novel in vitro model&#8221;
  * Kevin Haigis: &#8220;In vivo systems analysis of TNF-a responses in the intestinal epithelium&#8221;
  * Stacey Finley: &#8220;Predictive model of angiogenic factors in breast tumor tissue&#8221;
  * Edward Richards: &#8220;TAM family RTKs promote the metastatic niche at the tumor-immune interface through suppressing cytokine production in residing immune cell populations&#8221;

###### Poster session 2 (10:45am &#8211; 12p)

With coffee

###### Lunch (12:15 -1:30 pm)

###### Systems Pharmacology: Drug Resistance & Combinations (1:45p &#8211; 3:25 pm)

  * Invited Speaker: Frank Stegmeier: &#8220;Systematic Discovery of Cancer Vulnerabilities&#8221;
  * Benedict Anchang: &#8220;DRUGNEM: an optimized drug combination strategy using single-cell monotherapy perturbation response that accounts for intratumor heterogeneity&#8221;
  * Isaac Harris: &#8220;Functional profiling of metabolic liabilities in cancer&#8221;
  * Laura Heiser: &#8220;A systems biology paradigm to identify therapeutically relevant molecular networks in breast cancer&#8221;
  * Adam Palmer: &#8220;A curative combination therapy lacks synergy but eradicates drug resistance through independent modes of cell killing&#8221;

###### NCI Session 1 (3:45 &#8211; 5:15pm)

  * Invited Speaker: [Anne-Lise Børresen-Dale](http://ous-research.no/borresen/): &#8220;Multilevel molecular analyses in breast cancer: gauging inter- and intra-tumor heterogeneity and elucidating its role in treatment response.&#8221;
  * Invited Speaker: [Aaron Meyer](http://asmlab.org/): &#8220;Looking across resistance mechanisms to identify molecular commonalities and precision therapy approaches&#8221;

###### Lobster Dinner (5:30 &#8211; 7:00pm)

###### NCI Session 2 (7:15 &#8211; 8:45pm)

  * Invited Speaker: [Raghu Kalluri](http://www.raghukalluri.com), University of Texas
  * Invited Speaker: [Trey Ideker](http://healthsciences.ucsd.edu/som/medicine/research/labs/ideker/Pages/default.aspx): &#8220;The Cancer Cell Map Initiative&#8221;

## Wednesday, April 6th, 2016

* * *

###### Breakfast (7:00 &#8211; 8:30 am)

###### Signaling networks in Cancer (9:00 &#8211; 10:40 am)

  * Invited Speaker: [Kevin Janes](http://bme.virginia.edu/janes/index.html): &#8220;Pharmacologic Versus Genetic Targeting of Signaling Networks&#8221;
  * Maximilian Billman: &#8220;State-dependent genetic interactions identify switches in signaling networks&#8221;
  * Jacob Stewart-Ornstein: &#8220;Causes and consequences of p53 signaling dynamics in tissues and tumors&#8221;
  * Alexis Barr: &#8220;A dynamical framework for the all-or-none G1/S transition&#8221;
  * Danica Wiredja: &#8220;Integrating phosphoproteomics data for precision medicine: bioinformatics workflows identify cell cycle phosphoprotein dysregulation in KRAS mutated cell lines treated with novel activators of Protein Phosphatase 2A&#8221;

###### Keynote  (11:00 &#8211; 12:00pm)

[Gordon B. Mills](http://faculty.mdanderson.org/Gordon_Mills/): &#8220;Systems Approach to Cancer&#8221;